drugset / Trial / NCT02822287

Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough

NCT02822287

Phase 3 Completed 58 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelTreatment

Summary

This is a 1-treatment arm, open label design. This 1-day study includes a screening on day of attendance at clinic, followed by a washout period of 30 minutes to 8 hours (if participants are eligible for dosing the same day). The study also includes a supervised dosing with 10 mL oral solution and a 1 hour in-clinic evaluation period.

Timeline

Start
2016-02
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 10 ml Oral

Indications